BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16931474)

  • 1. Economic evaluations in pain management: principles and methods.
    Asche CV; Seal B; Jackson KC; Oderda GM
    J Pain Palliat Care Pharmacother; 2006; 20(3):15-23. PubMed ID: 16931474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis in oncology.
    Evans WK
    Praxis (Bern 1994); 2000 Mar; 89(12):492-6. PubMed ID: 10771589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analyses alongside randomised clinical trials.
    Gray AM
    Clin Trials; 2006; 3(6):538-42. PubMed ID: 17170038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpretation of "cost-effective" and soundness of economic evaluations in the pharmacy literature.
    Lee JT; Sanchez LA
    Am J Hosp Pharm; 1991 Dec; 48(12):2622-7. PubMed ID: 1814204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
    Führlinger S
    Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoeconomics.
    Ahuja J; Gupta M; Gupta AK; Kohli K
    Natl Med J India; 2004; 17(2):80-3. PubMed ID: 15141600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoeconomic concepts in antiplatelet therapy: understanding cost-effectiveness analyses using clopidogrel as an example.
    Weintraub WS
    J Cardiovasc Pharmacol Ther; 2008 Jun; 13(2):107-19. PubMed ID: 18495905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness as an outcome in randomized clinical trials.
    Hlatky MA; Owens DK; Sanders GD
    Clin Trials; 2006; 3(6):543-51. PubMed ID: 17170039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation for ophthalmologists.
    Kuper H; Jofre-Bonet M; Gilbert C
    Ophthalmic Epidemiol; 2006 Dec; 13(6):393-401. PubMed ID: 17169853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pain management: health economics and quality of life considerations].
    Phillips CJ
    Drugs; 2003; 63 Spec No 2():47-50. PubMed ID: 14758790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluations and randomized trials in spinal disorders: principles and methods.
    Korthals-de Bos I; van Tulder M; van Dieten H; Bouter L
    Spine (Phila Pa 1976); 2004 Feb; 29(4):442-8. PubMed ID: 15094541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of economic evaluation methods in the chronic pain medicine literature.
    Vetter TR
    Anesth Analg; 2007 Jul; 105(1):114-8. PubMed ID: 17578966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In search of the evidentiary foundation of published Canadian economic evaluations (2001-06).
    Tarride JE; Lim ME; Bowen JM; McCarron CE; Blackhouse G; Hopkins R; O'Reilly D; Xie F; Goeree R
    Int J Technol Assess Health Care; 2009 Apr; 25(2):214-21. PubMed ID: 19331712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methodology of economic assessment: example in oncology].
    Jaisson-Hot I; Schott AM; Clippe C; Ganne C; Hajri T; Poncet B; Trillet-Lenoir V; Colin C
    Bull Cancer; 2003 Nov; 90(11):939-45. PubMed ID: 14706896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches for economic evaluations of health care technologies.
    Tarride JE; Blackhouse G; Bischof M; McCarron EC; Lim M; Ferrusi IL; Xie F; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):307-16. PubMed ID: 19394571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
    Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
    J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACCP: economic evaluations of clinical pharmacy services: 2001-2005.
    Perez A; Doloresco F; Hoffman JM; Meek PD; Touchette DR; Vermeulen LC; Schumock GT;
    Pharmacotherapy; 2009 Jan; 29(1):128. PubMed ID: 19113803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A health economic model of breakthrough pain.
    Abernethy AP; Wheeler JL; Fortner BV
    Am J Manag Care; 2008 May; 14(5 Suppl 1):S129-40. PubMed ID: 18611101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical appraisal of published economic evaluations of home care for the elderly.
    Ramos ML; Ferraz MB; Sesso R
    Arch Gerontol Geriatr; 2004; 39(3):255-67. PubMed ID: 15381344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.